About Us

Mirimus is an award-winning New York biotech company advancing scientific research that drives medical breakthroughs. We tackle global health challenges by pioneering novel ways to diagnose and treat disease and by developing next-generation animal and cell models that power cutting-edge biomedical research. Founded in 2010, Mirimus has partnered with leading institutions around the world to expand its expertise in molecular diagnostics, genetic engineering, and therapeutics.

Our Founders

Prem Premsrirut, MD, PhD

President and CEO, Mirimus
Assistant Research Professor, Cell Biology, SUNY Downstate
Health Sciences University

Scott Lowe, PhD

Chair, Cancer Biology & Genetics, Memorial Sloan Kettering
Cancer Center
Investigator, Howard Hughes Medical Institute
Member, National Academy of Sciences

Stephen Elledge, PhD

Professor Genetics and Medicine, Harvard Medical School &
Brigham Women's Hospital
Investigator, Howard Hughes Medical Institute
Member, National Academy of Sciences
Lasker Award recipient

Christof Fellmann, PhD

Head of CRISPR-X, Executive Director, CRISPR Therapeutics
Assistant Professor, Gladstone Institute, Doudna Laboratory
Former CSO, Mirimus

Gregory Hannon, PhD

Director, Oncology & Non-coding RNAs, Cancer Research UK,
Cambridge Institute
Member, National Academy of Sciences

Our Leadership

Prem Premsrirut, MD, PhD

President and CEO, Mirimus
Assistant Research Professor, Cell Biology, SUNY Downstate
Health Sciences University

Veronica Andrews

Chief Operations Officer
Chief People Officer

David Eads

Chief Financial Officer

Our Scientists

Giuseppe Militello, PhD

Senior Scientific Director
Therapeutics and Nucleic Acid Biology
Genetic Engineering and RNA interference

Rosaline Sun, PhD

Associate Director of Cancer Biology
Cancer Biology and Genetics

Eduardo G. Reino, PhD

Director of Translational Research
Human genetics and Infectious diseases

Nicholas Gao, PhD

Associate Director of Cell-Based Modeling
Protein-DNA interactions and DNA replication

Our Advisors

Johannes Zuber, MD

Scientific Advisor
Senior Group Leader Research, Institute of Molecular Pathology (IMP), Adjunct
Professor, Medical University of Vienna
EMBO Member

Rachelle P. Mendoza, MD

Cytopathology and Scientific Advisor
Fellow in Anatomic Pathology (gynecology), University of Chicago
ABP Board Certified in Anatomic Pathology

Christopher E. Mason, PhD

Scientific Advisor
Associate Professor, Department of Physiology and Biophysics, Weill Cornell
Medicine

Lukas Dow, PhD

Scientific Advisor
Associate Professor, Weill Cornell Medicine

Aiqun Li, PhD

Scientific Advisor
Assistant Professor, Department of Genetics and
Genomic Sciences, Icahn School of Medicine at
Mount Sinai